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Background: Associations have been reported between irritable bowel syndrome
(IBS) and asthma.
Aims: To explore the inter-relations between these conditions in a general
population sample.
Subjects: A randomly selected community sample of 5492 adults.
Methods: All of the subjects were invited for a medical interview. Those subjects
suspected to have either asthma and/or IBS underwent spirometry with post-
bronchodilator test if indicated. The labeling of subjects as having IBS was based on
Rome II criteria.
Results: 4762 subjects agreed to take part (86.7% response). Prevalence rates for
IBS, and currently active asthma were 7.1% and 3.8%, respectively. Logistic
regression showed independent associations between IBS and most asthma symptom
categories. There was no significant independent association between IBS and
chronic bronchitis. The odds ratio with 95% confidence interval (CI) for IBS and
current asthma was 1.79 (1.06–3.03).
Conclusions: These observations indicate the necessity of further community-based
studies to elucidate the possible common pathogenic mechanisms involved in two
disease entities.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
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Association of irritable bowel syndrome (IBS) with
broncho-pulmonary disease was initially suspected
in 1991, when White and co-workers,1 showed that
IBS patients had an increased prevalence of
bronchial hyper-responsiveness. Seven years later,ed.
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showed IBS symptoms to be associated with
symptoms of bronchial hyper-responsiveness,2 so
it has been admitted that bronchial asthma might
be more prevalent in IBS patients than in control
subject.3 More recently, the prevalence of IBS had
been reported to be more in asthmatic patients
than in control subject.4
Most reports considering possible association
between asthma and IBS are case control studies
performed at secondary or tertiary referred hospi-
tals in highly selected patient groups.4 The only
available population-based study2 was based on
postal questionnaire and no clinical documentation
was provided.
The purpose of this study is to detect the possible
association between two conditions in a large
cohort of randomly selected subjects.Subjects and methods
A cross-sectional study was carried out in
2002–2003 on a randomly selected sample of adults
aged 20 years and over. The review board for
medical ethics of the Shahrekord medical school
approved the study and methods.
Assuming an estimated 5% prevalence rate for
both of the illnesses in the community, a sample of
1824 subjects was originally considered to be
satisfactory for the purpose. Since the cases had
to be selected by proportional random cluster
sampling, we decided to enroll at least two folds
more people in the study.
We used a two-step approach for the survey. In
the first step the Shahrekord urban area was
divided into 100 areas. Then we randomly selected
one lane from each area, by drawing lots, and all
the doors of the living places of the selected lanes
were knocked and all inhabitants 20 years of age or
older were invited to take part in interview and
complete the questionnaire.
In the second step those subjects who admitted
to have symptoms suggesting either IBS or asthma
or both, were invited to Hajar Medical Center for
further investigations including spirometry, and
stool examinations. Rectosigmoidoscopy was per-
formed if indicated.
In the second stage 1223 symptomatic subjects
meeting the above criteria were invited for
spirometry.
Forced vital capacity (FVC) maneuver was per-
formed in a standard fashion using an electronic
spirometer (Cybermedic, Louisville Co. 80027)
which was calibrated daily. Barometric pressuresmeasured daily showed a range of 596–600mmHg.
Room temperature was kept at 21–25 1C. The
subjects performed as many FVC maneuvers as
three consistent tests could be obtained or eight
maneuvers performed. The best of these attempts
for both forced expiratory flow at first second of
expiration (FEV1) and FVC was used to calculate the
ratio of (FEV1/FVC); this value is subsequently
referred to as the FEV/FVC%.
The tests included an initial spirometry supple-
mented by either post-exercise or post-broncho-
dilation repetition as necessary.
When the initial spirometry was normal the
subject was asked to jog for 10min and after a
5min resting, the spirometry was repeated and the
later test results were used for analysis. When
initial spirometry was obstructive, 10min after
inhalation of two puffs of Salbutamol (Ventolin)
spirometry was repeated to evaluate reversibility,
if an increament of 15% or more was noticed in
FEV1, the subject was assigned as having asthma,
if not it was labeled as COPD. Bronchial
hyper-reactivity was not assessed because many
individuals refused to inhale methacoline for
provocation.Questionnaire
The survey instrument was a standardized ques-
tionnaire in Persian designed by a working group in
Shahrekord; the gastro-intestinal questions were
based on the Rome II criteria,5 while respiratory
symptoms were detected using ECRHS respiratory
questionnaires.6 The questionnaire contained re-
sponse items looking into demographic data,
occupation, education level, asthma symptoms
and various bowel symptoms and the usual fre-
quency of bowel motions in the past 12 months.
Questions on bowel symptoms and asthma were
directly translated from the Rome II,5 and ECRHS
questionnaire,6 respectively, into an oral form of
Persian.
Major diagnostic symptoms of IBS were asked, that
is, abdominal pain or discomfort relieving with
defecation, and abdominal pain or discomfort asso-
ciated with changes in frequency or form of stool.
In respiratory part of questionnaire, major
diagnostic symptoms of asthma were asked; includ-
ing dyspneal attacks associated with wheezy
breathing ever in life and again during the past 12
months, exercise-induced dyspnea and wheeze,
and night sleep disturbed by dyspnea and/or cough.
History of physician prescribed inhaler medications
for dyspnea.
ARTICLE IN PRESS
B. Amra et al.112Subjects, who fulfilled the Rome II criteria for
IBS, were excluded from the study if any organic
bowel diseases such as cancer or inflammatory
bowel diseases were discovered in the second step
of the survey.
Training sessions by the authors were held to
educate medical students who had volunteered to
work as field investigators on IBS and the use of the
questionnaire.
Each patient was interviewed by medical stu-
dents on a day between August 2002 and March
2003 by four medical students.
An equal number of age and sex matched cases,
from those who did not report any IBS symptoms
were selected to be used as control group.
Validity and reproducibility of the
questionnaire
Four medical students completed interviews of 25
subjects with IBS, 25 subjects with asthma, 25
subjects with other gastrointestinal disorders and
25 subjects with other respiratory illnesses, in the
validation phase. They achieved a mean sensitivity
of 91% (87–100%) and specificity of 83% (71–92%).
The overall reproducibility of the diagnosis of IBS
conducted by these four investigators showed a
correlation coefficient of 0.75.Definitions(1) Based on the Rome II criteria, the diagnosis of
IBS was defined as at least 12 weeks of
abdominal pain or discomfort, which need not
be consecutive, in the past 12 months the
mentioned symptoms should have two out of
the three features below:
(i) relief with defecation; and/or
(ii) pain or discomfort associated with a
change in frequency of stool; and/or
(iii) pain or discomfort associated with a
change in the form (appearance) of stool.
(2) Asthma ever is: any history of dyspneal attacks
combined with wheezy breathing any time in
life.(3) Current asthma is: any history of dyspneal
attacks combined with wheezy breathing in
the last 12 months.(4) Obstructive spirometry is applied to those with
FEV1/FVC ratios of less than 75%.(5) Reversibility is defined as: increments of 15% or
more in FEV1, 10min after inhalation of two
puffs of Salbutamol via a metered dose inhaler.
Post-exercise decline of more than 15% in FEV1of individuals with initially normal spirometry,
is also interpreted as asthma and added to the
number of reversible obstructive subjects.(6) Chronic bronchitis is defined as productive
cough for more than three consecutive months
in at least two consecutive years in the absence
of any known etiology.Data analysis
Using statistical package for the social sciences
(SPSS Chicago, Il.l) the data were analyzed as
prevalence ratios for various diagnoses and/or
symptoms, and evidence of airway obstruction. w2
test was used to evaluate possible correlation
between subgroups with or without IBS symptom
categories, and also to evaluate correlation be-
tween symptom and possible risk factors including,
sex, smoking history, etc. Those variables with
initially significant effect (Po0:05) where selected
for logistic regression analysis and, odds Ratios and
95% confidence intervals (CIs) were calculated and
recorded.Results
The actual adult population of the selected 100
lanes was 5492, of whom 4762 subjects (86.71%)
agreed to take part in the study. The population
consisted of 2659 females (55.8%) and 2103 males
(44.2%) aged 20–92 (Mean7SD ¼ 37.90714.35).
The main reason for refusal was having no time.
Refusal was more frequent among men than among
women, which was attributed to their involvement
in business activities. Response rates for male and
females in first phase were 75.2% and 93.9%,
respectively.
The study population according to demographic
factors, smoking status and number of subjects
satisfactorily completing pulmonary function test-
ing, and also disease conditions are presented in
Table 1.
In 25 subjects with bowel symptoms the stool
examination was in favor of inflammatory bowel
disease. These 25 cases were excluded from the
study.
The frequency of respiratory disorders and
related symptoms, in IBS and non-IBS groups of
subjects are compared in Table 2.
Using multiple regression analysis, many initially
significant risk factors including: age, sex, smoking
habits, asthma ever and family history of asthma,
lost their significance and excluded from results.
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Table 1 Population selection, participation rates disease conditions.
Population No. (%)
Screening questionnaire 5492 (100)
Answered questionnaire 4762 (86.7)
Smoker 840 (17.6)
Asthma medication ever 359 (7.5)
Current asthma 179 (3.8)
IBS symptomatic subjects 337 (7.1)
Overlapping cases with both Asthma and IBS symptoms 32 (0.67)
Pulmonary function tests (PFT) 848 (17.81)
Reversible Obstructive PFT 64 (1.3)
Reversible Obstructive PFT in IBS 8 (2.9)
Table 2 Logistic regression analysis of risk factors in subjects with and without reported IBS.
Characteristics IBS cases No. (%) Non-IBS cases No. (%) OD (CR) P
Familial history of asthma 58 (17.2) 515 (11.6) 0.87 (0.52–1.46) 0.05
Current asthma 32 (9.5) 148 (3.3) 1.79 (1.06–3.03) 0.02
Asthma inhalers ever 83 (17.5) 276 (6.6) 1.63 (1.01–2.7) 0.05
Reversible obstructive PFT 8 (2.9) 56 (1.2) 1.61 (1.28–2.03) 0.026
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(7.1%), chronic bronchitis was strongly associated
with smoking (Po0:02) but not with IBS.
A total of 1008 subjects were invited for
spirometry of whom 848 responders (84.1%) under-
went pulmonary function testing, accompanied
with either a post-exercise or post-bronchodilator
reassessment. In 64 cases reversible airway’s
obstruction was detected. The results are included
in Table 2.Discussion
Our study was based on a random sample of adults
more than 20 years old in Shahrekord–Iran. The
methodology used in this study was robust. Sam-
pling was accurately random, the overall response
was good at 86.7% but female sex preponderance
might indicate lower participation rates for men.
Most non-participants told that they have no time
for the two-step survey, although it is possible that
a
’ ’
personal significance bias’’ influenced subjects’
likelihood to take part in the study, there is
evidence that most biases disappear when a
response rate of 70% or more is achieved.2
We investigated the associations between symp-
tom complexes; as it would be impractical to carry
out methacholine challenge testing and gastroin-
testinal endoscopy on 4762 subjects. We are awarethat not all subjects with the symptoms described
will have the underlying target condition, our loose
criteria to define asthma, cannot reliably exclude
other chronic conditions such as COPD, but this is
the major limitation for most of the epidemiologi-
cal surveys considering either asthma or IBS.
We tried to partially overcome the problem by
hiring professional interviewers, instead of self-
administered questionnaires alone, further-
more spirometries, and stool examinations, per-
formed in symptomatic subjects will help
to increase the reliability of the findings. This
method is more favorable to avoid the referral bias
inherent in secondary care based surveys of this
kind.
The sample size chosen was sufficiently large to
show significant associations between the selected
symptom groups and possibly disease conditions.
We have shown that symptoms of IBS, and
asthma-related symptoms occur more frequently
together than expected and that the conditions are
independently associated with each other.
Since two physiologically distinct systems are
involved by the two pathologic conditions, these
associations are difficult to explain.
One possible explanation is that the gastrointest-
inal and respiratory symptoms in our subjects are
caused by a common (but as yet unidentified)
underlying disorder, capable of producing symp-
toms in more than one physiological system and
resulting in an indirect association between see-
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mechanisms exist for this: one is a generalized
disorder of bronchial, gastrointestinal, and other
smooth muscle,7 another is a more complex
neuromuscular (afferent or efferent) disorder with
altered visceral sensitivity and shared transmitter
dysfunction.2 The third is the possibility of an
inflammatory etiology for the respiratory and
gastrointestinal symptoms.8 Since we have pro-
vided Spirometric support for the symptoms of
asthma, it is unlikely that the associations are a
product of a cognitive tendency to over report
among patients with IBS.
It has been suggested that IBS may follow a
pattern of pathogenesis that is similar to asthma
which was once considered psychosomatic disease.9
The immune system is being implicated in the
pathogenesis of psychosomatic disorder,10 if so, the
association might be more understandable.
It is evident that, a cross-sectional survey like
this, is incapable of determining the cause of the
strong associations which we have shown between
symptom groupings. The next research steps may
be to undertake studies in subjects similar to our
study population to determine the extent to which
symptomatic associations are mirrored in physiolo-
gical dysfunction. This would help in further
clarifying the reporting tendencies of these pa-
tients as well as investigating possible physiological
reasons for these associations.Conclusions
These observations indicate the necessity of
further community-based studies to elucidate thepossible common pathogenic mechanisms involved
in two disease entities.References
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